ENTITY

SCYNEXIS (SCYX US)

Health Care • United States

SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. SCYNEXIS serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any Insights right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00